| Original language | Undefined/Unknown |
|---|---|
| Pages (from-to) | E492-E502 |
| Journal | Lancet haematology |
| Volume | 2 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 2015 |
Cite this
}
Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials. / Maraldo, M.V.; Giusti, F.; Vogelius, I.R.; Lundemann, M.; van der Kaaij, M.A.E.; Ramadan, S.; Meulemans, B.; Henry-Amar, M.; Aleman, B.M.P.; Raemaekers, J.; Meijnders, P.; Moser, E.C.; Kluin-Nelemans, H.C.; Feugier, P.; Casasnovas, O; Fortpied, C.; Specht, L.
In: Lancet haematology, Vol. 2, No. 11, 2015, p. E492-E502.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials
AU - Maraldo, M.V.
AU - Giusti, F.
AU - Vogelius, I.R.
AU - Lundemann, M.
AU - van der Kaaij, M.A.E.
AU - Ramadan, S.
AU - Meulemans, B.
AU - Henry-Amar, M.
AU - Aleman, B.M.P.
AU - Raemaekers, J.
AU - Meijnders, P.
AU - Moser, E.C.
AU - Kluin-Nelemans, H.C.
AU - Feugier, P.
AU - Casasnovas, O
AU - Fortpied, C.
AU - Specht, L.
PY - 2015
Y1 - 2015
U2 - 10.1016/S2352-3026(15)00153-2
DO - 10.1016/S2352-3026(15)00153-2
M3 - Article
VL - 2
SP - E492-E502
JO - Lancet haematology
JF - Lancet haematology
SN - 2352-3026
IS - 11
ER -